{"filing":{"accession_number":"0001193125-26-276845","cik":"0001585608","ticker":"JAGX","company_name":"Jaguar Health, Inc.","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"d27128d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526276845/d27128d8k.htm"},"events":[{"id":12666,"run_id":11236,"accession_number":"0001193125-26-276845","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"Jaguar Health's Board has initiated a process to explore and review strategic alternatives \"focused on maximizing stockholder value,\" explicitly including \"mergers, reverse mergers, acquisitions, partnerships, joint ventures, licensing arrangements or other strategic transactions.\" This disclosure of an active exploration process for potential M\u0026A activity or change-of-control transactions is material to investors assessing the company's future direction and value, even though no specific transaction has been announced yet.","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9579,"accession_number":"0001193125-26-276845","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Jaguar Health's Board has initiated a process to explore and review strategic alternatives \"focused on maximizing stockholder value,\" explicitly including \"mergers, reverse mergers, acquisitions, partnerships, joint ventures, licensing arrangements or other strategic transactions.\" This disclosure of an active exploration process for potential M\u0026A activity or change-of-control transactions is material to investors assessing the company's future direction and value, even though no specific transaction has been announced yet.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T15:31:20.083676+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9579,"accession_number":"0001193125-26-276845","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Jaguar Health's Board has initiated a process to explore and review strategic alternatives \"focused on maximizing stockholder value,\" explicitly including \"mergers, reverse mergers, acquisitions, partnerships, joint ventures, licensing arrangements or other strategic transactions.\" This disclosure of an active exploration process for potential M\u0026A activity or change-of-control transactions is material to investors assessing the company's future direction and value, even though no specific transaction has been announced yet.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T15:31:20.083676+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-06-22"}]}